Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

3.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ebola Virus in Pregnancy.

Obstetrics and gynecology·2026
Same author

Leukocytic Dopamine D2 Receptors as Biomarkers for Brain Dopamine Levels in Parkinson Disease.

The American journal of pathology·2026
Same author

Glucose dysregulation and glycemic phenotyping in chronic migraine.

Frontiers in neurology·2026
Same author

Monocyte-Derived Macrophages Expressing Dopamine D2-Subtype Receptors Drive Alcohol Effects on Mesolimbic Neurons and Microglia.

Biomedicines·2025
Same author

Tularemia Antimicrobial Treatment and Prophylaxis: CDC Recommendations for Naturally Acquired Infections and Bioterrorism Response - United States, 2025.

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports·2025
Same author

Mpox Among Pregnant Women and Their Infants in the U.S. Outbreak, 2022-2023.

Obstetrics and gynecology·2025

Related Experiment Video

Updated: Dec 21, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.1K

Plague During Pregnancy: A Systematic Review.

Shannon Fleck-Derderian1,2, Christina A Nelson1, Katharine M Cooley3

  • 1Bacterial Diseases Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|May 22, 2020
PubMed
Summary

Plague during pregnancy poses significant risks to both mother and fetus. Prompt antimicrobial treatment is crucial for survival, though pregnancy loss remains a high risk. Maternal-fetal transmission of Yersinia pestis is possible.

Keywords:
Yersinia pestisfetalplaguepregnancy

More Related Videos

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

10.0K
Human Placental and Decidual Organ Cultures to Study Infections at the Maternal-fetal Interface
07:04

Human Placental and Decidual Organ Cultures to Study Infections at the Maternal-fetal Interface

Published on: July 21, 2016

21.5K

Related Experiment Videos

Last Updated: Dec 21, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.1K
Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

10.0K
Human Placental and Decidual Organ Cultures to Study Infections at the Maternal-fetal Interface
07:04

Human Placental and Decidual Organ Cultures to Study Infections at the Maternal-fetal Interface

Published on: July 21, 2016

21.5K

Area of Science:

  • Infectious Diseases
  • Maternal-Fetal Medicine
  • Public Health

Background:

  • Yersinia pestis (plague) is a global threat and bioterrorism agent.
  • Limited data exists on plague's impact on pregnancy outcomes.
  • Understanding maternal, fetal, and neonatal risks is critical.

Purpose of the Study:

  • To review and synthesize existing literature on plague during pregnancy.
  • To assess maternal and fetal outcomes associated with Yersinia pestis infection in pregnant individuals.

Main Methods:

  • Comprehensive literature search across 12 databases.
  • Inclusion of articles reporting plague in pregnancy with maternal or fetal outcomes.
  • Consultation with plague experts.

Main Results:

  • 160 cases of plague in pregnant women identified from 59 articles.
  • Maternal mortality was 29% and fetal fatality 62% with antimicrobial treatment.
  • Untreated cases showed higher mortality: 67% maternal, 74% fetal.
  • Evidence of Yersinia pestis transmission to fetus/neonate in 5 cases.

Conclusions:

  • Untreated plague in pregnancy leads to high maternal and fetal mortality.
  • Antimicrobial treatment improves maternal survival but pregnancy loss risk persists.
  • Maternal-fetal transmission of Yersinia pestis is possible, especially without treatment.
  • Urgent antimicrobial treatment or prophylaxis for pregnant women with suspected plague is essential.